SAN DIEGO, CA -- (MARKET WIRE) -- May 15, 2007 -- Inovio Biomedical Corporation (AMEX: INO), focused on the development of genetic vaccines for cancers and infectious diseases and a novel therapy to replace surgery for treating cancers, announced today that Michael Fons, Ph.D., Executive Director, Corporate Development, will present a corporate overview at the California Stock Report’s San Diego Growth Conference at 9:30 a.m. PT on Saturday, May 19, 2007 at the Hilton-La Jolla Torrey Pines hotel in La Jolla, California.
